Urology
Margin Recovery for Independent Urology Practices
Urology has one of the richest in-office procedural mixes in medicine, which means the margin question is usually about site of service, ancillary utilization, and whether the office is built to run procedures efficiently.
How the Economics Actually Work
The defining economic question in a urology practice is where the work happens. Procedures that can be performed safely in the office and are being sent to the hospital represent both a revenue transfer and a patient experience cost. Groups that have deliberately mapped their case mix against site-of-service options usually find real movement available.
Advanced prostate cancer therapy, in-office imaging, and pathology are meaningful ancillary lines with meaningful operational requirements. Each one lives or dies on authorization discipline, drug or supply acquisition cost, and scheduling that treats the resource — not the calendar slot — as the constraint.
The third factor is OR and ASC block behavior. Blocks that are held but under-filled are a fixed cost carried by the whole group, and release rules are usually informal, which means nobody is accountable when a block goes unused.
The Levers That Move Margin
These are the specific measurements we take. Each one is knowable from data you already have.
Site-of-service mapping
Case mix reviewed procedure by procedure against office, ASC, and hospital economics — including the staffing and supply cost of moving work in-office.
Advanced therapy and drug acquisition
Where a practice administers advanced therapies, acquisition cost, vial sizing, waste, and authorization workflow determine whether the line contributes margin or consumes it.
In-office imaging and lab utilization
Utilization against installed capacity, scheduling template fit, and turnaround time — the three things that decide whether an installed asset pays for itself.
OR and ASC block release discipline
Defined release windows and a utilization report by surgeon converts an informal courtesy into a managed asset.
APP leverage in the office
Advanced practice providers used at the top of licence expand physician procedural capacity. Used as overflow clinic coverage, they add cost without adding throughput.
Symptoms We Hear Most Often
If more than two of these describe your practice, there is measurable margin available.
- Procedures that could run in-office are routinely scheduled at the hospital
- Installed imaging or lab capacity sits idle on predictable days of the week
- Prior authorization for advanced therapy is a recurring fire drill
- Blocks are held out of tradition rather than measured utilization
- APPs are used to absorb overflow rather than to extend procedural capacity
How We Would Approach It
The same four-week baseline we run everywhere, pointed at the places that matter in this specialty.
Site-of-service and case mix analysis
We quantify the margin difference by procedure and site, including the true incremental cost of performing more work in-office.
Ancillary utilization review
Imaging, lab, and therapy lines measured against capacity, then rebuilt into the scheduling template so the asset drives the schedule.
Authorization workflow rebuild
Authorization moves upstream of scheduling with a hard rule and a named owner, which removes same-day cancellations and wasted drug.
Block utilization scorecard
A weekly report by surgeon with defined release rules, reviewed in the operating cadence rather than argued about after the fact.
On Consolidation
Large urology platforms have grown quickly by aggregating ancillary economics. An independent group can hold the same economics — it simply has to run them deliberately rather than incidentally.
Start with your numbers.
Thirty minutes, your actual data, and an honest read on where the margin is in a urology practice.